Detalles de la búsqueda
1.
2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors.
Arch Pharm (Weinheim)
; 356(11): e2300430, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37718357
2.
Deep eutectic solvent mediated synthesis of 3,4-dihydropyrimidin-2(1H)-ones and evaluation of biological activities targeting neurodegenerative disorders.
Bioorg Chem
; 118: 105457, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798458
3.
Design, Synthesis, and Biological Evaluation of Novel Dihydropyridine and Pyridine Analogs as Potent Human Tissue Nonspecific Alkaline Phosphatase Inhibitors with Anticancer Activity: ROS and DNA Damage-Induced Apoptosis.
Molecules
; 27(19)2022 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36234774
4.
Semicarbazones, thiosemicarbazone, thiazole and oxazole analogues as monoamine oxidase inhibitors: Synthesis, characterization, biological evaluation, molecular docking, and kinetic studies.
Bioorg Chem
; 115: 105209, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34364054
5.
Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors.
Bioorg Med Chem
; 27(13): 2741-2752, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31088715
6.
Synthesis, characterization, monoamine oxidase inhibition, molecular docking and dynamic simulations of novel 2,1-benzothiazine-2,2-dioxide derivatives.
Bioorg Chem
; 80: 498-510, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29996111
7.
Quinoline-sulfonamides as a multi-targeting neurotherapeutic for cognitive decline: in vitro, in silico studies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors.
RSC Adv
; 14(13): 8905-8920, 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38495980
8.
2,1-Benzothiazine - (quinolin/thiophen)yl hydrazone frameworks as new monoamine oxidase inhibitory agents; synthesis, in vitro and in silico investigation.
RSC Adv
; 13(3): 1701-1710, 2023 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36712607
9.
Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease.
RSC Adv
; 13(26): 17526-17535, 2023 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37304812
10.
Synthesis and Evaluation of Novel S-alkyl Phthalimide- and S-benzyl-oxadiazole-quinoline Hybrids as Inhibitors of Monoamine Oxidase and Acetylcholinesterase.
Pharmaceuticals (Basel)
; 16(1)2022 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36678507
11.
Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
Eur J Med Chem
; 181: 111560, 2019 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31382118
12.
Synthesis, X-ray crystal and monoamine oxidase inhibitory activity of 4,6-dihydrobenzo[c]pyrano[2,3-e][1,2]thiazine 5,5-dioxides: In vitro studies and docking analysis.
Eur J Pharm Sci
; 131: 9-22, 2019 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30735822
13.
Synthesis, monoamine oxidase inhibition activity and molecular docking studies of novel 4-hydroxy-N'-[benzylidene or 1-phenylethylidene]-2-H/methyl/benzyl-1,2-benzothiazine-3-carbohydrazide 1,1-dioxides.
Eur J Med Chem
; 143: 1373-1386, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29126721
Resultados
1 -
13
de 13
1
Próxima >
>>